Hospital In-Patient Insulin Study

Phase 4

Terminated

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT00135070
• Lead Sponsor: The Royal Bournemouth Hospital

Brief Summary

Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.

Detailed Description

This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar \> than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.

Study Timeline

• Study Start: 2005-07
• Study First Submitted: 2005-08-23
• Study First Submitted QC: 2005-08-23
• Study First Posted: 2005-08-25
• Study Completion: 2006-06
• Status Verified: 2007-04
• Last Update Submitted: 2007-04-27
• Last Update Posted: 2007-05-01

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

• Type II diabetes
• Blood glucose > 17mmols

Exclusion Criteria

• Type I diabetes
• Hyperosmolar non-ketotic coma (HONK)
• Diabetic ketoacidosis (DKA)
• Myocardial infarction (MI)
• Vomiting

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Glucose control

Secondary Outcome Measures

Name	Time	Method
Length of stay

Trial Locations

Locations (1)

The Royal Bournemouth Hospital; 🇬🇧 Bournemouth, Dorset, United Kingdom